Register | Log in | FAQ      [?] 

Tag hepatitis [64 articles]

Recent papers classified by the tag hepatitis.
  • Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection
    Drug and Alcohol Dependence, Vol. 73, No. 1. (7 January 2004), pp. 69-78.
    by I Kuo, SG Sherman, DL Thomas, SA Strathdee
    posted to hepatitis by zhlobko on 2005-02-11 09:33:42 as ***
  • Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections
    J. Virol., Vol. 82, No. 1. (1 January 2008), pp. 435-450.
    by Erik Depla, Annegret Van der Aa, Brian D Livingston, Claire Crimi, Koen Allosery, Veronique De Brabandere, Jonathan Krakover, Sidharta Murthy, Manley Huang, Scott Power, Lilia Babe, Carol Dahlberg, Denise Mckinney, Alessandro Sette, Scott Southwood, Ramilla Philip, Mark J Newman, Lydie Meheus
    posted to b epitope hepatitis t-lymphocyte vaccine virus by sci91078 on 2007-12-17 02:01:04 as *****
  • Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal.
    J Clin Microbiol, Vol. 40, No. 12. (December 2002), pp. 4493-4498.
    by J He, BL Innis, MP Shrestha, ET Clayson, RM Scott, KJ Linthicum, GG Musser, SC Gigliotti, LN Binn, RA Kuschner, DW Vaughn
    posted to e hepatitis nepal rodent by kblasdell on 2008-03-13 12:38:49 as **
  • Immune responses during acute and chronic infection with hepatitis C virus
    Clinical Immunology, Vol. 128, No. 2. (August 2008), pp. 133-147.
    by Shigeaki Ishii, Margaret J Koziel
  • Management of Chronic Hepatitis C in Veterans: The Potential of Integrated Care Models
    The American Journal of Gastroenterology, Vol. 103, No. 7. (July 2008), pp. 1810-1823.
  • Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity.
    J Virol, Vol. 78, No. 13. (July 2004), pp. 7257-7263.
    by ZY Keck, VM Sung, S Perkins, J Rowe, S Paul, TJ Liang, MM Lai, SK Foung
    posted to hepatitis hcv antibody by breden to the group FAB-lab on 2007-01-21 08:53:31 as ** along with 1 group SFUAntibodyResearch
  • Cloning, expression and identification of the gene of human single-chain variable fragment antibody against Hepatitis B virus surface antigen.
    Acta Virol, Vol. 50, No. 3. (2006), pp. 195-200.
    by YZ Lun, J Cheng, YW Zhong, BC Zhao
    posted to hepb hepatitis b antibody by breden to the group FAB-lab on 2007-01-20 19:15:10 as ** along with 1 group SFUAntibodyResearch
  • Recombinant human antibodies specific for hepatitis C virus proteins.
    Arch Virol, Vol. 142, No. 3. (1997), pp. 601-610.
    posted to hepatitis hcv antibody by breden to the group FAB-lab on 2007-01-21 08:39:53 as ** along with 1 group SFUAntibodyResearch
  • Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.
    J Virol, Vol. 80, No. 6. (March 2006), pp. 2654-2664.
    posted to hepatitis hcv c by breden to the group FAB-lab on 2007-01-20 19:20:09 as ** along with 1 group SFUAntibodyResearch
  • Improvement of neutralizing activity of human scFv antibodies against hepatitis B virus binding using CDR3 V(H) mutant library.
    Viral Immunol, Vol. 19, No. 1. (2006), pp. 115-123.
    by SG Park, YJ Jung, YY Lee, CM Yang, IJ Kim, JH Chung, IS Kim, YJ Lee, SJ Park, JN Lee, SK Seo, YH Park, IH Choi
    posted to hepb hepatitis b antibody by breden to the group FAB-lab on 2007-01-20 19:18:26 as ** along with 1 group SFUAntibodyResearch
  • Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1.
    J Virol, Vol. 75, No. 24. (December 2001), pp. 12412-12420.
    by C Li, D Candotti, JP Allain
    posted to hepatitis hcv antibody by breden to the group FAB-lab on 2007-01-21 00:32:51 as ** along with 1 group SFUAntibodyResearch
  • Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display.
    Virology, Vol. 318, No. 2. (20 January 2004), pp. 598-607.
    by SJ Kim, MH Jang, JT Stapleton, SO Yoon, KS Kim, ES Jeon, HJ Hong
    posted to hepatitis hav antibody by breden to the group FAB-lab on 2007-01-21 08:57:41 as ** along with 1 group SFUAntibodyResearch
  • Generation of high affinity human single-chain antibody against PreS1 of hepatitis B virus from immune phage-display antibody library.
    Hepatobiliary Pancreat Dis Int, Vol. 3, No. 1. (February 2004), pp. 77-81.
    by ZC Zhang, XJ Hu, Q Yang
    posted to hepatitis hbv antibody by breden to the group FAB-lab on 2007-01-21 08:58:46 as ** along with 1 group SFUAntibodyResearch
  • Avoid the tragedy of hepatitis B reactivation in immunosuppressed patients
    Nat Clin Pract Gastroenterol Hepatol, Vol. 4, No. 3. (March 2007), pp. 128-129.
    by Julie A Foont, Eugene R Schiff
    posted to hepatitis inmunosupresion by gerardobucaramanga on 2007-03-07 13:26:18 as **
  • The hepatitis C virus 3'-untranslated region or a poly(A) tract promote efficient translation subsequent to the initiation phase.
    Nucleic Acids Res, Vol. 34, No. 4. (2006), pp. 1293-1303.
    posted to enhancer hepatitis initiation translation utr virus by eckart_bindewald on 2007-04-27 13:13:35 as **
  • The influence of the human genome on chronic viral hepatitis outcome.
    Rev Inst Med Trop Sao Paulo, Vol. 46, No. 3. (n 2004), pp. 119-126.
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 02:18:57 as **
  • Hepatitis C and liver fibrosis.
    Cell Death Differ, Vol. 10 Suppl 1 (January 2003)
    by D Schuppan, A Krebs, M Bauer, EG Hahn
    posted to hepatitis tgf by dyctiostelium on 2005-11-18 07:48:15 as **
  • The dinucleotide microsatellite polymorphism of the IFNAR1 gene promoter correlates with responsiveness of hepatitis C patients to interferon.
    Hepatol Res, Vol. 25, No. 3. (March 2003), pp. 221-225.
    by Noriko Matsuyama, Shunji Mishiro, Masanobu Sugimoto, Yasuhiro Furuichi, Michie Hashimoto, Minako Hijikata, Yasuhiko Ohta
    posted to c hepatitis prognosis by dyctiostelium on 2005-11-18 07:09:36 as ****
  • Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.
    Hepatology, Vol. 30, No. 2. (August 1999), pp. 526-530.
    posted to hepatitis by dyctiostelium on 2005-11-18 07:25:25 as ***
  • Natural killer cells inhibit hepatitis C virus expression.
    J Leukoc Biol, Vol. 76, No. 6. (December 2004), pp. 1171-1179.
    by Y Li, T Zhang, C Ho, JS Orange, SD Douglas, WZ Ho
    posted to hepatitis nk tgf by dyctiostelium on 2005-11-20 08:37:58 as **
  • Analysis of the transforming growth factor-beta1 (TGF-beta1) codon 25 gene polymorphism by LightCycler-analysis in patients with chronic hepatitis C infection.
    Cytokine, Vol. 24, No. 5. (7 December 2003), pp. 173-181.
    posted to hepatitis tgf by dyctiostelium on 2005-11-19 23:12:02 as ***
  • Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.
    J Exp Med, Vol. 195, No. 1. (7 January 2002), pp. 35-41.
    posted to hepatitis nk by dyctiostelium on 2005-11-20 08:45:09 as **
  • Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection.
    Clin Exp Immunol, Vol. 109, No. 3. (September 1997), pp. 451-457.
    by J Corado, F Toro, H Rivera, NE Bianco, L Deibis, JB De Sanctis
    posted to hepatitis nk by dyctiostelium on 2005-11-20 08:49:25 as **
  • Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.
    N Engl J Med, Vol. 350, No. 22. (27 May 2004), pp. 2265-2271.
    by AJ Muir, JD Bornstein, PG Killenberg,
    posted to hepatitis polimorfism by dyctiostelium on 2005-11-21 06:41:32 as **
  • HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1.
    Exp Mol Med, Vol. 37, No. 2. (30 April 2005), pp. 138-145.
    by JY Shin, W Hur, JS Wang, JW Jang, CW Kim, SH Bae, SK Jang, SH Yang, YC Sung, OJ Kwon, SK Yoon
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 01:56:53 as **
  • [The role of hepatitis C virus core protein on liver fibrogenesis: a study using an in vitro co-culture system]
    Korean J Gastroenterol, Vol. 42, No. 5. (November 2003), pp. 400-408.
    by JY Shin, SK Yoon, JS Wang, W Hur, JS Ryu, SH Bae, JY Choi, JM Yang, SH Yang, YC Sung, KW Chung, HS Sun
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 02:21:31 as **
  • Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.
    Gut, Vol. 54, No. 1. (January 2005), pp. 142-151.
    by L Xu, AY Hui, E Albanis, MJ Arthur, SM O'Byrne, WS Blaner, P Mukherjee, SL Friedman, FJ Eng
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 03:20:44 as **
  • Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
    J Interferon Cytokine Res, Vol. 20, No. 2. (February 2000), pp. 143-151.
    by EE Tredget, R Wang, Q Shen, PG Scott, A Ghahary
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 08:09:52 as **
  • Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.
    Hepatology, Vol. 33, No. 3. (March 2001), pp. 708-712.
    by LJ Yee, J Tang, AW Gibson, R Kimberly, DJ Van Leeuwen, RA Kaslow
    posted to hepatitis by dyctiostelium on 2005-11-18 07:22:30 as ***
  • Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro and in vivo.
    World J Gastroenterol, Vol. 11, No. 26. (14 July 2005), pp. 4045-4051.
    by M Chen, GJ Wang, Y Diao, RA Xu, HT Xie, XY Li, JG Sun
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 00:15:53 as **
  • The immunologic basis for hepatitis C infection.
    Curr Opin Gastroenterol, Vol. 20, No. 6. (November 2004), pp. 598-602.
    by J Sun, K Li, MT Shata, TS Chan
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 08:33:19 as **
  • (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells.
    Hepatology, Vol. 27, No. 4. (April 1998), pp. 1003-1012.
    by S Roth, K Michel, AM Gressner
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 03:00:50 as ****
  • Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
    J Immunol, Vol. 160, No. 5. (1 March 1998), pp. 2539-2545.
    by K Ohtsuka, JD Gray, MM Stimmler, B Toro, DA Horwitz
    posted to hepatitis nk tgf by dyctiostelium on 2005-11-20 05:26:30 as **
  • Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.
    Immunogenetics, Vol. 55, No. 6. (September 2003), pp. 362-369.
    by S Knapp, BJ Hennig, AJ Frodsham, L Zhang, S Hellier, M Wright, R Goldin, AV Hill, HC Thomas, MR Thursz
    posted to c hepatitis prognosis by dyctiostelium on 2005-11-18 07:01:18 as ****
  • Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells.
    Gastroenterology, Vol. 129, No. 1. (July 2005), pp. 246-258.
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 01:30:22 as **
  • Galectin-1 is an inductor of pancreatic stellate cell activation.
    Cell Signal, Vol. 17, No. 10. (October 2005), pp. 1240-1247.
    posted to hepatitis by dyctiostelium on 2005-12-21 01:45:59 as **
  • Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy.
    J Med Virol, Vol. 65, No. 3. (November 2001), pp. 510-516.
    posted to hepatitis by dyctiostelium on 2005-11-18 07:19:16 as ***
  • Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection.
    J Infect Dis, Vol. 187, No. 8. (15 April 2003), pp. 1264-1271.
    by LJ Yee, KA Perez, J Tang, DJ van Leeuwen, RA Kaslow
    posted to hepatitis by dyctiostelium on 2005-11-18 07:12:27 as ***
  • A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals.
    J Leukoc Biol, Vol. 76, No. 6. (December 2004), pp. 1180-1186.
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 08:35:34 as **
  • Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice.
    Hepatology, Vol. 38, No. 4. (October 2003), pp. 890-899.
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 04:31:49 as **
  • Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells.
    Gastroenterology, Vol. 126, No. 2. (February 2004), pp. 529-540.
    by R Bataller, YH Paik, JN Lindquist, JJ Lemasters, DA Brenner
    posted to hepatitis tgf by dyctiostelium on 2005-11-20 02:17:04 as **
  • Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.
    World J Gastroenterol, Vol. 11, No. 13. (7 April 2005), pp. 1929-1936.
    posted to hepatitis by dyctiostelium on 2005-11-18 07:37:47 as ***
  • Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.
    Gastroenterology, Vol. 119, No. 6. (December 2000), pp. 1637-1648.
    posted to critical gi hepatitis icu by dbs on 2007-04-03 02:26:15 as **
  • notes Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
    J Hepatol, Vol. 36, No. 4. (April 2002), pp. 480-487.
    posted to critical gi hepatitis icu by dbs on 2007-04-03 02:25:11 as **
  • Peginterferon and ribavirin for chronic hepatitis C.
    N Engl J Med, Vol. 355, No. 23. (7 December 2006), pp. 2444-2451.
    by JH Hoofnagle, LB Seeff
    posted to gi hepatitis id by dbs on 2007-03-08 00:14:53 as ** along with 1 person Amazoness
  • Non-alcoholic fatty liver disease and hepatitis C infection.
    Minerva Gastroenterol Dietol, Vol. 52, No. 2. (June 2006), pp. 135-143.
    by S Bondini, ZM Younossi
    posted to c hepatitis metabolic nafld syndrome by DarsDakota on 2008-02-07 03:50:46 as **
  • Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection
    BMC Infectious Diseases, Vol. 5, No. 1. (2005)
    by Cengiz Bolukbas, Fusun Bolukbas, Mehmet Horoz, Mehmet Aslan, Hakim Celik, Ozcan Erel
    posted to b hepatitis oxidative stress by DarsDakota on 2008-02-07 03:55:34 as **
  • Nursing staff knowledge of the hepatitis B virus including attitudes and acceptance of hepatitis B vaccination: development of an effective program.
    AAOHN J, Vol. 51, No. 8. (August 2003), pp. 347-352.
    posted to helaht hepatitis promotion by astaines on 2004-11-24 00:15:36
  • [Clinico-immunological aspects of chronic hepatitis of viral etiology]
    Ter Arkh, Vol. 56, No. 2. (1984), pp. 83-86.
    by IuV Tel'nykh, VKh Khavinson, VG Morozov, VT Ivashkin
    posted to chronic clinical hepatitis viral by anush on 2005-06-23 02:51:43 as **
  • [Treatment with thymalin of severe and recurring forms of viral hepatitis]
    Klin Med (Mosk), Vol. 61, No. 11. (November 1983), pp. 109-113.
    by BI Kuznik, VKh Khavinson, VG Morozov, GB Budazhabon, VG Pateiuk
    posted to hepatitis thymalin viral by anush on 2005-06-23 03:07:45 as ****
  • Note: You may cite this page as: http://www.citeulike.org/tag/hepatitis

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.